A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ann Oncol
Prif Awduron: Dunn, L A, Fury, M G, Xiao, H, Baxi, S S, Sherman, E J, Korte, S, Pfister, C, Haque, S, Katabi, N, Ho, A L, Pfister, D G
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2018
Pynciau:
Corrigenda
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6888018/
https://ncbi.nlm.nih.gov/pubmed/29300804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx801
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg